Akebia Therapeutics | AKBA - Cost Of Sales


Akebia Therapeutics reported $10.34M in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Acadia Pharmaceuticals USD 28.32M 3.52M Jun/2026
Agios Pharmaceuticals USD 1.32M 560K Mar/2026
Akebia Therapeutics USD 10.34M 441K Dec/2025
Alnylam Pharmaceuticals USD 298.45M 87.33M Jun/2026
Amgen USD 1.87B 271M Jun/2026
Ardelyx USD 4.81M 6.04M Mar/2026
Astellas Pharma JPY 158.38B 28.94B Jun/2026
AstraZeneca USD 2.52B 2.73B Jun/2026
Bayer EUR 4.54B 692M Jun/2026
BioMarin Pharmaceutical USD 276.29M 76.8M Jun/2026
Celltrion KRW 92.83B 14.59B Mar/2026
Cspc Pharmaceutical CNY 2.11B 173.58M Dec/2025
Deva Holding AS TRY 991.13M 182.81M Sep/2023
Exelixis USD 20.66M 704K Jun/2026
Fresenius Medical Care EUR 3.55B 117.58M Jun/2026
GlaxoSmithKline GBP 2.07B 192M Jun/2026
Ionis Pharmaceuticals USD 2.74M 261K Jun/2026
Ironwood Pharmaceuticals USD 29.83M 560K Sep/2024
J&J USD 8B 67M Jun/2026
Kangmei Pharma CNY 841.45M 271.27M Mar/2026
Karyopharm Therapeutics USD 1.34M 139K Mar/2026
Knight Therapeutics CAD 82.22M 1.03M Dec/2025
Laboratorios Farma EUR 186.09M 11.06M Dec/2023
Lexicon Pharmaceuticals USD 201K 191K Dec/2025
Medical Developments International AUD 7.09M 4.91M Dec/2025
Moderna USD 93M 862M Jun/2026
Nektar Therapeutics USD 4.43M 5.3M Sep/2024
Neuren Pharmaceuticals AUD 7.45M 6.56M Jun/2025
Organigram Holdings CAD 43.39M 13.54M Mar/2026
Pharma Mar EUR 4.73M 1.08M Jun/2026
Prothena USD 28.94M 11.58M Sep/2025
PTC Therapeutics USD 39.61M 23.31M Mar/2026
Qiagen NV USD 196.45M 13.73M Jun/2026
Regeneron Pharmaceuticals USD 576.5M 92.9M Jun/2026
Roche Holding CHF 7.85B 630M Jun/2026
Sanofi EUR 3.02B 656M Jun/2026
Sarepta Therapeutics USD 150.1M 40.64M Jun/2026
Sartorius EUR 478.7M 5.9M Jun/2026
Sino Biopharmaceutical CNY 3.08B 589.65M Jun/2025
Tilray USD 164.37M 8.41M Sep/2025
Vanda Pharmaceuticals USD 198.77M 151.12M Dec/2024
Zealand Pharma A/S 410K 5K Jun/2025
Zz Pientze Pharmaceu CNY 1.58B 245.15M Mar/2026